近日，由行业媒体“医学界”与“同写意”共同发起的首届创新药“华山奖”在上海揭晓。信达生物荣获“2026最佳成长型医药企业奖”，彰显了行业对信达生物创新实力与持续发展潜力的高度认可。“华山奖”立足专业立场、国际标准、民间评价和中国榜样，旨在发现中国创新药价值医疗标杆。以做中国最有影响力的创新药奖项为愿景，笃行科学专业立场、树立行业标杆、激励源头创新、助力产业升级的使命，秉持拥抱未来医学、坚持循证医学...
Source Link近日，由行业媒体“医学界”与“同写意”共同发起的首届创新药“华山奖”在上海揭晓。信达生物荣获“2026最佳成长型医药企业奖”，彰显了行业对信达生物创新实力与持续发展潜力的高度认可。“华山奖”立足专业立场、国际标准、民间评价和中国榜样，旨在发现中国创新药价值医疗标杆。以做中国最有影响力的创新药奖项为愿景，笃行科学专业立场、树立行业标杆、激励源头创新、助力产业升级的使命，秉持拥抱未来医学、坚持循证医学...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.